ArticleFrontiers in bioengineering and biotechnology2025
An explainable deep learning framework for biosensing data interpretation in biomedical engineering and real-time health diagnostics.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This work proposes an explainable deep learning framework to transform complex biosignal dynamics into interpretable health assessments. The core of our approach is the PhysioGraph Inference Network (PGIN), which combines temporal graph reasoning with probabilistic modeling to capture dynamic inter sensor dependencies under physiological priors. Methods: To further enhance adaptability, an Adaptive Health State Inference Mechanism (AHSIM) is introduced to adjust diagnostic granularity based on uncertainty and signal entropy. Results and discussion: Evaluations on four biosensing datasets show that our framework achieves superior diagnostic accuracy (up to 92.48%) and AUC (up to 93.65%), outperforming several transformer-based baselines such as RoBERTa and T5. Furthermore, the model provides transparent uncertainty estimates, making it suitable for deployment in clinical and wearable scenarios. By integrating physiological semantics and model interpretability, our framework bridges the gap between black-box AI and trustworthy biomedical intelligence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.